Delta-like ligand 4-notch signaling in macrophage activation

Toshiaki Nakano, Daiju Fukuda, Jun Ichiro Koga, Masanori Aikawa

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

The Notch signaling pathway regulates the development of various cell types and organs, and also contributes to disease mechanisms in adults. Accumulating evidence suggests its role in cardiovascular and metabolic diseases. Notch signaling components also control the phenotype of immune cells. Delta-like ligand 4 (Dll4) of the Notch pathway promotes proinflammatory activation of macrophages in vitro and in vivo. Dll4 blockade attenuates chronic atherosclerosis, vein graft disease, vascular calcification, insulin resistance, and fatty liver in mice. The Dll4-Notch axis may, thus, participate in the shared mechanisms for cardiometabolic disorders, serving as a potential therapeutic target for ameliorating these global health problems.

Original languageEnglish
Pages (from-to)2038-2047
Number of pages10
JournalArteriosclerosis, thrombosis, and vascular biology
Volume36
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Macrophage Activation
Vascular Calcification
Metabolic Diseases
Fatty Liver
Insulin Resistance
Veins
Atherosclerosis
Cardiovascular Diseases
Transplants
Phenotype
delta protein
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Delta-like ligand 4-notch signaling in macrophage activation. / Nakano, Toshiaki; Fukuda, Daiju; Koga, Jun Ichiro; Aikawa, Masanori.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 36, No. 10, 01.10.2016, p. 2038-2047.

Research output: Contribution to journalReview article

Nakano, Toshiaki ; Fukuda, Daiju ; Koga, Jun Ichiro ; Aikawa, Masanori. / Delta-like ligand 4-notch signaling in macrophage activation. In: Arteriosclerosis, thrombosis, and vascular biology. 2016 ; Vol. 36, No. 10. pp. 2038-2047.
@article{2848e4e6dea540faaee096ab816c9a1d,
title = "Delta-like ligand 4-notch signaling in macrophage activation",
abstract = "The Notch signaling pathway regulates the development of various cell types and organs, and also contributes to disease mechanisms in adults. Accumulating evidence suggests its role in cardiovascular and metabolic diseases. Notch signaling components also control the phenotype of immune cells. Delta-like ligand 4 (Dll4) of the Notch pathway promotes proinflammatory activation of macrophages in vitro and in vivo. Dll4 blockade attenuates chronic atherosclerosis, vein graft disease, vascular calcification, insulin resistance, and fatty liver in mice. The Dll4-Notch axis may, thus, participate in the shared mechanisms for cardiometabolic disorders, serving as a potential therapeutic target for ameliorating these global health problems.",
author = "Toshiaki Nakano and Daiju Fukuda and Koga, {Jun Ichiro} and Masanori Aikawa",
year = "2016",
month = "10",
day = "1",
doi = "10.1161/ATVBAHA.116.306926",
language = "English",
volume = "36",
pages = "2038--2047",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Delta-like ligand 4-notch signaling in macrophage activation

AU - Nakano, Toshiaki

AU - Fukuda, Daiju

AU - Koga, Jun Ichiro

AU - Aikawa, Masanori

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The Notch signaling pathway regulates the development of various cell types and organs, and also contributes to disease mechanisms in adults. Accumulating evidence suggests its role in cardiovascular and metabolic diseases. Notch signaling components also control the phenotype of immune cells. Delta-like ligand 4 (Dll4) of the Notch pathway promotes proinflammatory activation of macrophages in vitro and in vivo. Dll4 blockade attenuates chronic atherosclerosis, vein graft disease, vascular calcification, insulin resistance, and fatty liver in mice. The Dll4-Notch axis may, thus, participate in the shared mechanisms for cardiometabolic disorders, serving as a potential therapeutic target for ameliorating these global health problems.

AB - The Notch signaling pathway regulates the development of various cell types and organs, and also contributes to disease mechanisms in adults. Accumulating evidence suggests its role in cardiovascular and metabolic diseases. Notch signaling components also control the phenotype of immune cells. Delta-like ligand 4 (Dll4) of the Notch pathway promotes proinflammatory activation of macrophages in vitro and in vivo. Dll4 blockade attenuates chronic atherosclerosis, vein graft disease, vascular calcification, insulin resistance, and fatty liver in mice. The Dll4-Notch axis may, thus, participate in the shared mechanisms for cardiometabolic disorders, serving as a potential therapeutic target for ameliorating these global health problems.

UR - http://www.scopus.com/inward/record.url?scp=84983748408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983748408&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.116.306926

DO - 10.1161/ATVBAHA.116.306926

M3 - Review article

VL - 36

SP - 2038

EP - 2047

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 10

ER -